Value of Immunizations during the COVID-19 Emergency

Stefanati, Armando; d’Anchera, Erica; Motoli, Francesco De; Savio, Marta; Toffoletto, Maria Vittoria; Gabutti, Giovanni

doi:10.3390/ijerph18020778

Cited by 14 publications

(7 citation statements)

References 13 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Accompanying preventive measures with vaccination is essential to overcome the coronavirus disease 2019 (COVID-19) pandemic [1] , [2] . The vaccination program against COVID-19 began in December 2020 [3] .…”

Section: Introductionmentioning

confidence: 99%

Side effects of Sputnik V, Oxford–AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran

Oghazian

Tamanaei

Haghighi

et al. 2023

International Immunopharmacology

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Side effects of Sputnik V, Oxford–AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran

Oghazian

Tamanaei

Haghighi

et al. 2023

International Immunopharmacology

View full text Add to dashboard Cite

“…Global efforts to face coronavirus disease 19 (COVID-19) rely primarily on the preventive measures implied by individuals to decrease the likelihood of infection transmission [ 1 ]. Consequently, the role of COVID-19 vaccinations in complementing the individual preventive measures to face the pandemic has become vital, and vaccination coverage is regarded as critical for maintaining efficient public health measures [ 2 ]. Since the availability of COVID-19 vaccines, governments worldwide have exerted tremendous efforts to execute effective procurement and vaccination programs for individuals [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

COVID-19 Vaccination Attitudes, Perceptions, and Side Effect Experiences in Malaysia: Do Age, Gender, and Vaccine Type Matter?

et al. 2021

View full text Add to dashboard Cite

This study aimed to investigate the attitudes, perceptions, and experiences of side effects with the COVID-19 vaccines in Malaysia among participants in the National Vaccination Program. A cross-sectional survey was conducted among a sample of vaccine-eligible and vaccinated individuals in Malaysia between May and July 2021. A total of 428 respondents completed the survey. A vast majority (98.6%) of the respondents had registered to be vaccinated. Twenty participants (4.7%) expressed concerns about either registering or receiving the COVID-19 vaccination, mainly due to their uncertainty of vaccine safety. Approximately 77.5% received their vaccinations. Of them, 76.8% had experienced vaccine-related side effects. About 40% of the side effects occurred more with the second dose, particularly those who received the Pfizer-BioNTech vaccine (p < 0.0005). Pain at the injection site (61.1%) and tiredness (48.8%) were the most reported side effects. Compared to those aged ≥60 years, all age groups were more likely to exhibit vaccine-related side effects; meanwhile, males (OR: 0.51, 95% CI: 0.27–0.93) were less likely to experience side effects than females. Those who received the Sinovac vaccine were at lower risk of experiencing side effects (OR: 0.08, 95% CI: 0.03–0.22) and were more likely to report fewer side effects than Pfizer-BioNTech (p = 0.012) and Oxford-AstraZeneca groups (p = 0.001). The overall attitudes toward the COVID-19 vaccination program were positive. Several differences in the experiences of vaccine-related side effects, in terms of prevalence and numbers, were attributed to age, gender, and received vaccine type.

show abstract

“…To counteract this, a series of actions could be implemented, such as enhanced outreach services, supplementary immunisation activity, and strengthening routine immunisation data systems [ 36 ]. Monitoring VPD outbreaks and ensuring systematic real-time data collection has been crucial to allow for early diagnosis and case management [ 37 ].…”

Section: Discussionmentioning

confidence: 99%

Driving Paediatric Vaccine Recovery in Europe

et al. 2023

View full text Add to dashboard Cite

Background: Childhood vaccination coverage has increased throughout Europe in recent decades. However, challenges persist in many areas within the European Union (EU), resulting in declining coverage rates in many countries in the period between 2010 and 2021. This general trend requires increased efforts to combat barriers around vaccination uptake. Thus, this article aims to summarise key learnings and trends in paediatric vaccination within the EU, with a focus on current challenges and enablers. Methods: Methodology is based on analysis of primary data, mainly vaccination coverage rates, as well as review and analysis of the select relevant literature, including peer-reviewed articles, academic research papers, official reports, policies, and other publicly available sources. Results: For all vaccines assessed (DTP 1st dose, DTP 3rd dose, Hib3, HepB3, measles 1st dose, measles 2nd dose, and polio 3rd dose), a high degree of variation and fluctuation in coverage can be observed. There is a general trend of declining coverage in 2019 compared to 2010, with lower performing countries, such as Romania and Austria, showing increasingly severe coverage fluctuations between the years examined across the analysed vaccines. Conclusions: Evidence suggests that increasing both accessibility and information regarding vaccines are key enablers to vaccination uptake. Moreover, given the current challenges the EU is facing, crisis preparedness plans are pertinent to ensure immunity gaps do not further exacerbate the disruption of vaccination systems.

show abstract

Value of Immunizations during the COVID-19 Emergency

Cited by 14 publications

References 13 publications

Side effects of Sputnik V, Oxford–AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran

Side effects of Sputnik V, Oxford–AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran

COVID-19 Vaccination Attitudes, Perceptions, and Side Effect Experiences in Malaysia: Do Age, Gender, and Vaccine Type Matter?

Driving Paediatric Vaccine Recovery in Europe

Contact Info

Product

Resources

About